dry eye disease

Sun Pharma launches CEQUA for treatment of dry eye disease in US
Pharmaceutical Business Review
Mon, 10/14/19 - 09:41 am
Sun Pharma
dry eye disease
Cequa
drug launches
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Mon, 10/7/19 - 10:57 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Oyster Point Pharma Files for $85 Million IPO
Mon, 10/7/19 - 10:09 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
FDA wants additional data on Kala Pharma’s KPI-121
Pharma Letter
Fri, 08/9/19 - 10:43 am
Kala Pharmaceuticals
KP-121
dry eye disease
FDA
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
FDA
AbbVie
upadacatinib
Roche
Ignyta
entrectinib
Kala Pharmaceuticals
KPI-121
dry eye disease
Allegro announces positive results of ex-US proof-of-concept trial with ALG-1007 for dry eye disease
Pharmaceutical Business Review
Wed, 05/15/19 - 11:47 pm
Allegro
clinical trials
ALG-1007
dry eye disease
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Takeda
Shire
Novartis
M&A
Xiidra
dry eye disease
Oyster Point raises $93M series B to bring dry eye nasal spray to FDA
BioCentury
Tue, 02/26/19 - 09:38 am
Oyster Point
dry eye disease
OC-01
OC-02
Sylentis' dry eye drug misses primary goals in phase 3
Fierce Biotech
Thu, 01/31/19 - 11:55 pm
Sylentis
dry eye disease
PharmaMar
siRNA
tivanisiran
clinical trials
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Endpoints
Tue, 01/22/19 - 11:43 am
Aurinia Pharmaceuticals
voclosporin
eye health
dry eye disease
Allergan
Restasis
Oyster Point's OC-01 dry eye nasal spray meets in Phase IIb
BioCentury
Wed, 10/24/18 - 10:16 am
Oyster Point
dry eye disease
OC-01
clinical trials
Kala seeks FDA nod for dry eye disease drug
Drug Delivery Business News
Tue, 10/16/18 - 11:34 am
Kala Pharmaceuticals
FDA
KPI-121
dry eye disease
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial
Fierce Biotech
Wed, 09/26/18 - 10:02 am
Aldeyra Therapeutics
dry eye disease
clinical trials
reproxalap
Sun Pharma receives USFDA nod for ophthalmic solution used to treat dry eye disease
Economic Times, India
Thu, 08/16/18 - 01:54 pm
Sun Pharma
FDA
India
dry eye disease
Cequa
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Thu, 07/12/18 - 11:49 am
Oyster Point
OC-02
dry eye disease
Allergan
Restasis
Shire
Xiidra
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
CP Wire
Fri, 04/13/18 - 09:49 am
Allergan
devices
TrueTear
dry eye disease
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
Fri, 04/13/18 - 11:54 am
Allergan
dry eye disease
TrueTear
Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire
Xtalks
Wed, 03/21/18 - 10:55 am
Ocugen
dry eye disease
OCU310
Shire
Allergan
Restasis
Xiidra
Kala Pharma reveals mixed Ph3 data for dry eye disease drug
Drug Delivery Business News
Fri, 01/5/18 - 05:29 pm
Kala Pharmaceuticals
dry eye disease
KPI-121
Allergan inks $13M settlement in whistleblower marketing suit
Fierce Pharma
Wed, 07/5/17 - 11:20 am
Allergan
kickbacks
physicians
dry eye disease
Restasis
whistleblower lawsuits

Pages